Alsius (ALUS) Announces FDA Clearance to Market Solex(TM) Heat Exchange Catheter

August 26, 2008 7:58 AM EDT

Alsius Corporation (Nasdaq: ALUS) today announced that the U.S. FDA has granted the company 510(k) clearance to market the Solex(TM) heat exchange catheter.

Solex is a new catheter, developed by Alsius, that advances the company's leadership in intravascular patient temperature management. Solex offers clinicians maximum heat exchange power from a standard neck insertion, while providing triple lumen central venous access.

Alsius Corporation develops, manufactures, markets, and sells catheter-based intravascular temperature management products to control patient temperature in hospital critical care settings.

Related Categories

FDA

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?